 Xiaofan Jia
Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nutrition Surveys | 23 | 2024 | 262 | 2.470 |
Why?
| | China | 38 | 2024 | 192 | 2.380 |
Why?
| | Diet | 17 | 2024 | 1214 | 2.050 |
Why?
| | Diabetes Mellitus, Type 1 | 9 | 2023 | 3629 | 1.580 |
Why?
| | Cognitive Dysfunction | 3 | 2024 | 346 | 1.320 |
Why?
| | Celiac Disease | 3 | 2023 | 289 | 0.930 |
Why?
| | Zinc Transporter 8 | 2 | 2021 | 86 | 0.930 |
Why?
| | Autoantibodies | 7 | 2023 | 1473 | 0.920 |
Why?
| | Choline | 1 | 2024 | 117 | 0.870 |
Why?
| | Energy Intake | 4 | 2024 | 454 | 0.850 |
Why?
| | Dietary Proteins | 1 | 2024 | 132 | 0.850 |
Why?
| | Cohort Studies | 19 | 2024 | 5431 | 0.780 |
Why?
| | Obesity, Abdominal | 4 | 2024 | 48 | 0.760 |
Why?
| | High-Throughput Screening Assays | 2 | 2020 | 138 | 0.760 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 253 | 0.730 |
Why?
| | Autoimmune Diseases | 2 | 2020 | 426 | 0.650 |
Why?
| | Dyslipidemias | 3 | 2024 | 177 | 0.610 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2018 | 7 | 0.590 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2440 | 0.590 |
Why?
| | Antibodies, Viral | 2 | 2023 | 607 | 0.580 |
Why?
| | Middle Aged | 36 | 2024 | 31322 | 0.560 |
Why?
| | Ascorbic Acid | 1 | 2018 | 123 | 0.560 |
Why?
| | Nutritional Status | 5 | 2024 | 328 | 0.550 |
Why?
| | Feeding Behavior | 7 | 2024 | 621 | 0.540 |
Why?
| | Aged | 24 | 2024 | 22282 | 0.520 |
Why?
| | Adult | 38 | 2024 | 35711 | 0.500 |
Why?
| | Fruit | 5 | 2021 | 131 | 0.500 |
Why?
| | Mass Screening | 3 | 2021 | 1139 | 0.490 |
Why?
| | Young Adult | 25 | 2024 | 12404 | 0.480 |
Why?
| | Prevalence | 11 | 2024 | 2576 | 0.470 |
Why?
| | Hyperuricemia | 2 | 2024 | 45 | 0.460 |
Why?
| | Biomarkers | 3 | 2024 | 3923 | 0.460 |
Why?
| | Adolescent | 30 | 2024 | 20374 | 0.460 |
Why?
| | Hypertension | 4 | 2024 | 1245 | 0.450 |
Why?
| | Female | 37 | 2024 | 68842 | 0.400 |
Why?
| | Vegetables | 5 | 2024 | 147 | 0.400 |
Why?
| | Humans | 51 | 2024 | 130305 | 0.390 |
Why?
| | Male | 35 | 2024 | 63748 | 0.390 |
Why?
| | Cholesterol, Dietary | 3 | 2016 | 18 | 0.380 |
Why?
| | Luminescent Measurements | 2 | 2021 | 78 | 0.360 |
Why?
| | Obesity | 5 | 2024 | 2869 | 0.360 |
Why?
| | Snacks | 2 | 2022 | 19 | 0.340 |
Why?
| | Waist Circumference | 3 | 2024 | 138 | 0.320 |
Why?
| | Risk Factors | 13 | 2024 | 9865 | 0.310 |
Why?
| | Incidence | 3 | 2024 | 2657 | 0.280 |
Why?
| | Prospective Studies | 6 | 2024 | 7131 | 0.280 |
Why?
| | Cross-Sectional Studies | 7 | 2024 | 5083 | 0.270 |
Why?
| | Urbanization | 3 | 2022 | 25 | 0.260 |
Why?
| | Body Mass Index | 7 | 2024 | 2268 | 0.260 |
Why?
| | Gastrointestinal Microbiome | 2 | 2024 | 638 | 0.250 |
Why?
| | Eating | 3 | 2024 | 368 | 0.240 |
Why?
| | Glutamate Decarboxylase | 2 | 2022 | 166 | 0.240 |
Why?
| | Mental Status and Dementia Tests | 2 | 2021 | 23 | 0.230 |
Why?
| | Iron, Dietary | 1 | 2024 | 21 | 0.230 |
Why?
| | Mycobiome | 1 | 2024 | 11 | 0.230 |
Why?
| | Selenium | 1 | 2024 | 37 | 0.230 |
Why?
| | Multimorbidity | 1 | 2024 | 45 | 0.230 |
Why?
| | Seroepidemiologic Studies | 2 | 2023 | 158 | 0.230 |
Why?
| | Copper | 1 | 2024 | 109 | 0.220 |
Why?
| | Dietary Carbohydrates | 1 | 2024 | 152 | 0.220 |
Why?
| | Metabolic Diseases | 1 | 2024 | 106 | 0.210 |
Why?
| | Micronutrients | 2 | 2021 | 86 | 0.210 |
Why?
| | Overweight | 2 | 2024 | 526 | 0.200 |
Why?
| | Dietary Fats | 1 | 2024 | 303 | 0.200 |
Why?
| | Pediatric Obesity | 2 | 2021 | 573 | 0.200 |
Why?
| | Sex Factors | 3 | 2024 | 1965 | 0.200 |
Why?
| | Nutritional Requirements | 2 | 2024 | 77 | 0.200 |
Why?
| | Osteopontin | 1 | 2022 | 33 | 0.200 |
Why?
| | Stroke | 2 | 2024 | 1119 | 0.190 |
Why?
| | C-Reactive Protein | 1 | 2024 | 396 | 0.190 |
Why?
| | Mental Status Schedule | 1 | 2021 | 34 | 0.190 |
Why?
| | Child Nutrition Disorders | 1 | 2021 | 18 | 0.190 |
Why?
| | Electrochemistry | 1 | 2021 | 81 | 0.190 |
Why?
| | Zinc | 1 | 2024 | 294 | 0.190 |
Why?
| | Child | 10 | 2023 | 20961 | 0.180 |
Why?
| | Electrochemical Techniques | 1 | 2020 | 48 | 0.170 |
Why?
| | Sensitivity and Specificity | 2 | 2022 | 1854 | 0.170 |
Why?
| | Lymphopenia | 1 | 2020 | 60 | 0.170 |
Why?
| | Rural Population | 4 | 2024 | 507 | 0.170 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 107 | 0.170 |
Why?
| | Longitudinal Studies | 6 | 2024 | 2691 | 0.160 |
Why?
| | Logistic Models | 3 | 2021 | 1980 | 0.160 |
Why?
| | Malnutrition | 1 | 2020 | 78 | 0.160 |
Why?
| | Nutrition Policy | 1 | 2019 | 56 | 0.160 |
Why?
| | Diabetes Mellitus | 2 | 2024 | 1005 | 0.160 |
Why?
| | Age Factors | 2 | 2024 | 3153 | 0.160 |
Why?
| | Phosphoproteins | 1 | 2021 | 333 | 0.150 |
Why?
| | Calcium, Dietary | 1 | 2018 | 56 | 0.150 |
Why?
| | Food, Preserved | 1 | 2018 | 2 | 0.150 |
Why?
| | Autoantigens | 1 | 2021 | 417 | 0.150 |
Why?
| | Diet Surveys | 3 | 2024 | 93 | 0.150 |
Why?
| | Vitamin A | 1 | 2018 | 56 | 0.150 |
Why?
| | Nuts | 1 | 2018 | 12 | 0.150 |
Why?
| | Health Status | 1 | 2023 | 756 | 0.150 |
Why?
| | Beverages | 1 | 2018 | 67 | 0.140 |
Why?
| | Urban Population | 3 | 2024 | 439 | 0.140 |
Why?
| | Nutrition Assessment | 1 | 2018 | 85 | 0.140 |
Why?
| | Anthropometry | 1 | 2018 | 206 | 0.140 |
Why?
| | Socioeconomic Factors | 2 | 2019 | 1200 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 266 | 0.140 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 349 | 0.140 |
Why?
| | Neuropsychological Tests | 1 | 2021 | 1004 | 0.140 |
Why?
| | Aged, 80 and over | 3 | 2024 | 7128 | 0.140 |
Why?
| | Cardiovascular Diseases | 3 | 2024 | 2028 | 0.130 |
Why?
| | Proteomics | 1 | 2022 | 1008 | 0.120 |
Why?
| | Patient Compliance | 1 | 2019 | 565 | 0.120 |
Why?
| | Follow-Up Studies | 2 | 2021 | 4961 | 0.120 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1341 | 0.120 |
Why?
| | Infant | 4 | 2023 | 9049 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 361 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 356 | 0.120 |
Why?
| | Child, Preschool | 4 | 2023 | 10514 | 0.110 |
Why?
| | Colorado | 2 | 2023 | 4471 | 0.110 |
Why?
| | Cognition | 1 | 2021 | 1110 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2021 | 3369 | 0.110 |
Why?
| | Cholesterol, LDL | 1 | 2015 | 361 | 0.110 |
Why?
| | Prognosis | 1 | 2021 | 3830 | 0.100 |
Why?
| | Depression | 1 | 2021 | 1298 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2020 | 1058 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 5400 | 0.090 |
Why?
| | Hepatitis B | 1 | 2010 | 62 | 0.080 |
Why?
| | Liver Failure | 1 | 2010 | 93 | 0.080 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2010 | 491 | 0.080 |
Why?
| | Chronic Disease | 2 | 2024 | 1727 | 0.080 |
Why?
| | Mass Spectrometry | 1 | 2010 | 664 | 0.070 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1235 | 0.060 |
Why?
| | Metabolomics | 1 | 2010 | 599 | 0.060 |
Why?
| | Blood Pressure | 2 | 2023 | 1753 | 0.060 |
Why?
| | Transglutaminases | 1 | 2023 | 155 | 0.050 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2021 | 17 | 0.050 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.050 |
Why?
| | Fasting | 1 | 2022 | 265 | 0.040 |
Why?
| | Asymptomatic Infections | 1 | 2020 | 23 | 0.040 |
Why?
| | Virus Shedding | 1 | 2020 | 44 | 0.040 |
Why?
| | Zoonoses | 1 | 2020 | 28 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2020 | 150 | 0.040 |
Why?
| | Multilevel Analysis | 1 | 2020 | 27 | 0.040 |
Why?
| | Cities | 1 | 2020 | 104 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 523 | 0.040 |
Why?
| | Genome, Viral | 1 | 2020 | 132 | 0.040 |
Why?
| | Virulence | 1 | 2020 | 255 | 0.040 |
Why?
| | Farmers | 1 | 2020 | 67 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2020 | 264 | 0.040 |
Why?
| | Meat Products | 1 | 2018 | 25 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 340 | 0.040 |
Why?
| | Seafood | 1 | 2018 | 27 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2022 | 593 | 0.040 |
Why?
| | Body Composition | 1 | 2022 | 658 | 0.040 |
Why?
| | Plants, Edible | 1 | 2018 | 8 | 0.040 |
Why?
| | Exercise | 2 | 2020 | 1941 | 0.040 |
Why?
| | Carotenoids | 1 | 2018 | 38 | 0.040 |
Why?
| | Dairy Products | 1 | 2018 | 36 | 0.040 |
Why?
| | Recommended Dietary Allowances | 1 | 2018 | 19 | 0.040 |
Why?
| | Eggs | 1 | 2018 | 31 | 0.040 |
Why?
| | Cost of Illness | 1 | 2020 | 292 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2019 | 485 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3069 | 0.040 |
Why?
| | Population Surveillance | 1 | 2020 | 429 | 0.040 |
Why?
| | Weight Loss | 1 | 2023 | 728 | 0.040 |
Why?
| | Meat | 1 | 2018 | 93 | 0.040 |
Why?
| | Autoimmunity | 1 | 2023 | 867 | 0.030 |
Why?
| | Educational Status | 1 | 2019 | 467 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2020 | 509 | 0.030 |
Why?
| | Animals | 4 | 2022 | 35076 | 0.030 |
Why?
| | Disease Management | 1 | 2020 | 597 | 0.030 |
Why?
| | Phylogeny | 1 | 2020 | 847 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2020 | 730 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2020 | 467 | 0.030 |
Why?
| | Health Surveys | 1 | 2018 | 495 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 578 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 939 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2021 | 795 | 0.030 |
Why?
| | Hypercholesterolemia | 1 | 2015 | 101 | 0.030 |
Why?
| | Critical Illness | 1 | 2020 | 761 | 0.030 |
Why?
| | Inflammation | 1 | 2024 | 2721 | 0.030 |
Why?
| | Regression Analysis | 1 | 2015 | 991 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 3084 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2639 | 0.020 |
Why?
| | Blood Glucose | 1 | 2022 | 2100 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1928 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1538 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3310 | 0.020 |
Why?
| | Glycerylphosphorylcholine | 1 | 2010 | 6 | 0.020 |
Why?
| | Hospitalization | 1 | 2020 | 2094 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2010 | 187 | 0.020 |
Why?
| | Aging | 1 | 2020 | 1785 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2010 | 148 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6615 | 0.020 |
Why?
| | United States | 1 | 2023 | 14110 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 10341 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2321 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2020 | 14675 | 0.010 |
Why?
| | Rats | 1 | 2010 | 5285 | 0.010 |
Why?
|
|
Jia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|